Protocols

First-line therapy

• LPHD Trial

  Observational study for lymphocyte predominance Hodgkin's lymphoma stage IA

• HD13 Trial (early stages)

  Quality assurance protocol to reduce toxicities following first-line therapy for early stage Hodgkin's disease

• HD14 Trial (intermediate stages)

  Quality assurance protocol to improve efficacy of the first-line therapy of intermediate stage Hodgkin's disease

• HD15 Trial (advanced stages)

  Quality assurance protocol to reduce toxicities and to determine the prognostic significance of FDG-PET imaging in first-line therapy of advanced stage Hodgkin's disease

Protocols and documents of the previous trial generation HD10-12.

Salvage therapy

HD-R2 Trial

Sequential high-dose chemotherapy with autologous stem cell transplantation in relapsed Hodgkin's lymphoma

GHSG meeting

An annual meeting addressed to the members of the GHSG aims to present recent results of the GHSG trials and new therapy strategies.

Furthermore the opportunity to discuss problems and to resolve difficulties is given.